Neuropsychiatric symptoms in at-risk groups for AD dementia and their association with worry and AD biomarkers-results from the DELCODE study.

Lena SannemannAnn-Katrin SchildSlawek AltensteinClaudia BartelsFrederic BrosseronKatharina BuergerNicoleta Carmen CosmaKlaus FliessbachSilka Dawn FreieslebenWenzel GlanzMichael T HenekaDaniel JanowitzIngo KilimannXenia KobelevaChristoph LaskeCoraline D MetzgerMatthias H J MunkRobert PerneczkyOliver PetersAlexandra PolcherJosef PrillerBoris RauchmannChristina RöschJanna RudolphAnja SchneiderAnnika SpottkeEike Jakob SpruthStefan TeipelRuth VukovichMichael WagnerJens WiltfangSteffen WolfsgruberEmrah DuezelFrank Jessennull null

Published in: Alzheimer's research & therapy (2020)

German Clinical Trials Register DRKS00007966 . Registered 4 May 2015.

Keyphrases

clinical trial
mild cognitive impairment
randomized controlled trial
sleep quality
depressive symptoms